Pacific Biosciences (PACB - Get Report) is feeling so confident about its offering, that its lifted its original filing from $200 million to $230 million. Biotech IPOs haven't received warm welcomes of late and Pacific Biosciences is in an increasingly crowded DNA sequencing field.
Plus, this market wants proven companies and Pacific Biosciences is all about potential. The company has already raised $400 million in venture capital money, while having lost $63 million for six months ending June 2010.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts